Global Transcatheter Aortic Valve Replacement (TAVR) Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application

Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
The classification of Transcatheter Aortic Valve Replacement (TAVR) includes transfemoral approach, transapical approach and others. The proportion of transfemoral approach in 2017 is about 83%.
Transcatheter Aortic Valve Replacement (TAVR) is widely used for aortic stenosis, aortic regurgitation and other diseases. The most proportion of Transcatheter Aortic Valve Replacement (TAVR) is used for aortic regurgitation, and the proportion in 2017 is 76%.

Market Analysis and Insights: Global Transcatheter Aortic Valve Replacement (TAVR) Market
The research report studies the Transcatheter Aortic Valve Replacement (TAVR) market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Transcatheter Aortic Valve Replacement (TAVR) market size is projected to reach US$ XX million by 2026, from US$ 3979.4 million in 2020, at a CAGR of XX% during 2021-2026.

Global Transcatheter Aortic Valve Replacement (TAVR) Scope and Segment
The global Transcatheter Aortic Valve Replacement (TAVR) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transcatheter Aortic Valve Replacement (TAVR) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.

Segment by Type, the Transcatheter Aortic Valve Replacement (TAVR) market is segmented into
Transfemoral Approach
Transapical Approach
Others

Segment by Application, the Transcatheter Aortic Valve Replacement (TAVR) market is segmented into
Aortic Stenosis
Aortic Regurgitation
Others

Global Transcatheter Aortic Valve Replacement (TAVR) market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

The major vendors covered:
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences

Frequently Asked Questions